BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 10753944)

  • 21. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
    Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
    J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta.
    Mori Y; Chen SJ; Varga J
    Exp Cell Res; 2000 Aug; 258(2):374-83. PubMed ID: 10896788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smad7 is a TGF-beta-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis.
    Zhao J; Crowe DL; Castillo C; Wuenschell C; Chai Y; Warburton D
    Mech Dev; 2000 May; 93(1-2):71-81. PubMed ID: 10781941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.
    Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
    Zhang Y; Musci T; Derynck R
    Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
    Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    Feng XH; Lin X; Derynck R
    EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta.
    Vindevoghel L; Lechleider RJ; Kon A; de Caestecker MP; Uitto J; Roberts AB; Mauviel A
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14769-74. PubMed ID: 9843964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced smad-dependent transcriptional activation.
    Stroschein SL; Wang W; Luo K
    J Biol Chem; 1999 Apr; 274(14):9431-41. PubMed ID: 10092624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning of Smad2, Smad3, Smad4, and Smad7 from the goldfish pituitary and evidence for their involvement in activin regulation of goldfish FSHbeta promoter activity.
    Lau MT; Ge W
    Gen Comp Endocrinol; 2005 Mar; 141(1):22-38. PubMed ID: 15707600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.
    Poncelet AC; Schnaper HW
    J Biol Chem; 2001 Mar; 276(10):6983-92. PubMed ID: 11114293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene.
    Costamagna E; GarcĂ­a B; Santisteban P
    J Biol Chem; 2004 Jan; 279(5):3439-46. PubMed ID: 14623893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7.
    Quan T; He T; Voorhees JJ; Fisher GJ
    J Biol Chem; 2001 Jul; 276(28):26349-56. PubMed ID: 11320083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of Smad signaling in transcription of Smad7 gene mediated by TGF-beta1 in odontoblast cell line MDPC-23].
    He WX; Niu ZY; Zhao SL; Zang XX; Gao J; Li P
    Shanghai Kou Qiang Yi Xue; 2005 Apr; 14(2):143-6. PubMed ID: 15886838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical role of Smads and AP-1 complex in transforming growth factor-beta -dependent apoptosis.
    Yamamura Y; Hua X; Bergelson S; Lodish HF
    J Biol Chem; 2000 Nov; 275(46):36295-302. PubMed ID: 10942775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smad7 mediates transforming growth factor-beta-induced apoptosis in mesangial cells.
    Okado T; Terada Y; Tanaka H; Inoshita S; Nakao A; Sasaki S
    Kidney Int; 2002 Oct; 62(4):1178-86. PubMed ID: 12234288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun/c-Fos proteins.
    Liang CL; Chen JL; Hsu YP; Ou JT; Chang YS
    J Biol Chem; 2002 Jun; 277(26):23345-57. PubMed ID: 11971895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smad3 and Smad4 mediate transforming growth factor-beta1-induced IgA expression in murine B lymphocytes.
    Park SR; Lee JH; Kim PH
    Eur J Immunol; 2001 Jun; 31(6):1706-15. PubMed ID: 11385614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells.
    Bilezikjian LM; Corrigan AZ; Blount AL; Chen Y; Vale WW
    Endocrinology; 2001 Mar; 142(3):1065-72. PubMed ID: 11181520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.